OLMA Cyrus Harmon sells $96K worth of shares
Sep 19, 2025, 4:38 AM
0.00%
What does OLMA do
Olema Pharmaceuticals, based in San Francisco, develops targeted therapies for women's cancers, notably its lead candidate OP-1250, currently in Phase I/II trials for metastatic ER-positive breast cancer. The company went public on November 19, 2020, and employs 75 staff.
Cyrus Harmon sold 11,914 shares of OLMA on 16 September at $8.08 per share, worth a total of $96K. They now own 754,140 OLMA shares, or a 9% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.